Announcements

Ryan Cohlhepp, President and Chief Operating Officer of Bicara Therapeutics Inc., filed a Form 4 on August 12, 2026, disclosing the exercise of stock options and the sale of 18,750 shares of common stock on August 10, 2026, pursuant to a Rule 10b5-1 trading …

A Form 4 filed on August 12, 2026, discloses that John Dietrich Pauls, President and CEO of DiaMedica Therapeutics Inc. (NASDAQ:DMAC), acquired 60,200 restricted stock units on August 10, 2026, at a price of $0.

A Form 4 filed with the SEC on August 12, 2026 discloses that Axogen, Inc. director Amy McBride-Wendell exercised stock options and sold 13,353 shares of common stock on August 11, 2026, pursuant to a pre-established Rule 10b5-1 trading plan.

A Form 4 filed on August 12, 2026, reports that Frederick A. Forthuber, a director of Western Midstream Partners, LP (NYSE:WES), purchased 5,140 common units representing limited partner interests on August 12, 2026, at a price of $48.62 per unit.

Marc A. Began, Executive Vice President and General Counsel of Axogen, Inc. (NASDAQ:AXGN), filed a Form 4 on August 12, 2026, disclosing the exercise of 67,500 stock options and the same-day sale of 67,500 shares of common stock on August 10, 2026, pursuant to …

Kamal Anthony Hatoum, Chairman and CEO of BBB Foods Inc, filed a Form 4 on August 12, 2026, disclosing a conversion of 16,003,914 Class C Common Shares into an equal number of Class A Common Shares on August 7, 2026, held indirectly through Bolton …

Ahmad A. Khan, President of Semiconductor Process and Customer Operations at KLA Corp, filed a Form 4 on August 12, 2026, disclosing the sale of 33,180 shares of common stock on August 11, 2026.